This update workshop brought together global regulators, academicians, drug developers, and CRO scientists. The focus of the workshop was on providing information on the latest project developments with the goal for there to be a high level of participant interaction.
CIPA Update Workshop, Rechanneling the Current Cardiac Paradigm: Arrhythmia Risk Assessment During Drug Development Without the Thorough QT Study
December 11, 2014
Silver Spring, Maryland, USA